J. Ycas

1.5k total citations
24 papers, 1.0k citations indexed

About

J. Ycas is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J. Ycas has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J. Ycas's work include Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). J. Ycas is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). J. Ycas collaborates with scholars based in United States, United Kingdom and Canada. J. Ycas's co-authors include Jay Horrow, Bertram Pitt, Joseph Loscalzo, Joel S. Raichlen, Richard C. Becker, Nils Åsenblad, Lars Wallentin, Robert F. Storey, Christopher P. Cannon and Benjamin D. Horne and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Medicine and The American Journal of Cardiology.

In The Last Decade

J. Ycas

23 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Ycas United States	11	550	512	158	157	126	24	1.0k
Heinz Drexel Austria	17	454 0.8×	255 0.5×	50 0.3×	238 1.5×	77 0.6×	51	1.2k
Gabriella Iannuzzo Italy	19	339 0.6×	407 0.8×	75 0.5×	185 1.2×	43 0.3×	73	965
Clapton Dias United States	14	253 0.5×	392 0.8×	118 0.7×	50 0.3×	110 0.9×	20	1.4k
Issa Alesh United States	9	367 0.7×	519 1.0×	130 0.8×	233 1.5×	128 1.0×	21	982
Tadeusz Osadnik Poland	21	489 0.9×	360 0.7×	57 0.4×	133 0.8×	50 0.4×	71	1.2k
J. Shawn Miles United States	6	661 1.2×	792 1.5×	93 0.6×	226 1.4×	111 0.9×	8	1.6k
Michel Zeitouni France	17	753 1.4×	597 1.2×	71 0.4×	101 0.6×	59 0.5×	71	1.3k
Srikanth Yandrapalli United States	19	611 1.1×	258 0.5×	66 0.4×	161 1.0×	36 0.3×	94	1.0k
Lars Lindhagen Sweden	16	679 1.2×	390 0.8×	88 0.6×	63 0.4×	47 0.4×	55	1.1k
Tingfei Hu United States	13	771 1.4×	826 1.6×	131 0.8×	267 1.7×	58 0.5×	17	1.4k

Countries citing papers authored by J. Ycas

Since Specialization

Citations

This map shows the geographic impact of J. Ycas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ycas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ycas more than expected).

Fields of papers citing papers by J. Ycas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ycas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ycas. The network helps show where J. Ycas may publish in the future.

Co-authorship network of co-authors of J. Ycas

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ycas. A scholar is included among the top collaborators of J. Ycas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ycas. J. Ycas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Capell, Warren H., et al.. (2026). Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial. Circulation Cardiovascular Interventions. e015229–e015229.

Canonico, Mario Enrico, Cecilia C. Low Wang, Judith Hsia, et al.. (2024). Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization. Journal of the American College of Cardiology. 84(9). 801–811. 2 indexed citations

Ycas, J.. (2017). Toward a Blood-Borne Biomarker of Chronic Hypoxemia: Red Cell Distribution Width and Respiratory Disease. Advances in clinical chemistry. 82. 105–197. 24 indexed citations

Wu, Bingcao, et al.. (2015). Applying Weighting Methodologies to a Commercial Database to Project US Census Demographic Data. The American Journal of Managed Care. 3. 23 indexed citations

Ycas, J., Jay Horrow, & Benjamin D. Horne. (2015). Persistent increase in red cell size distribution width after acute diseases: A biomarker of hypoxemia?. Clinica Chimica Acta. 448. 107–117. 89 indexed citations

Wasser, Thomas, Bingcao Wu, J. Ycas, Ozgur Tunceli, & Mark J. Cziraky. (2013). Establishing a weighting methodology to compute the number of patients with disease using claims data and census population in the united states. Value in Health. 16(3). A23–A23. 1 indexed citations

Storey, Robert F., Stefan James, Agneta Siegbahn, et al.. (2013). Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study. Platelets. 25(7). 517–525. 126 indexed citations

Wasser, Thomas, Bingcao Wu, J. Ycas, Ozgur Tunceli, & Mark J. Cziraky. (2013). Comparison of commercial insurance databases to census data for age, gender and geographic region in the united states. Value in Health. 16(3). A22–A23. 4 indexed citations

Storey, Robert F., Philippe Gabríel Steg, Stefan James, et al.. (2012). REDUCTION IN PULMONARY ADVERSE EVENTS AND ASSOCIATED SEPSIS AND MORTALITY IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH TICAGRELOR COMPARED TO CLOPIDOGREL: A POST HOC ANALYSIS OF THE PLATO STUDY. Journal of the American College of Cardiology. 59(13). E482–E482. 3 indexed citations

10.

Held, Claes, Nils Åsenblad, Jean Pierre Bassand, et al.. (2010). Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery. Journal of the American College of Cardiology. 57(6). 672–684. 331 indexed citations

11.

Pitt, Bertram, Joseph Loscalzo, J. Ycas, & Joel S. Raichlen. (2008). Lipid Levels After Acute Coronary Syndromes. Journal of the American College of Cardiology. 51(15). 1440–1445. 128 indexed citations

12.

Ferdinand, Keith C., et al.. (2008). Relationship of Ethnic Origin, Gender, and Age to Blood Creatine Kinase Levels. The American Journal of Medicine. 122(1). 73–78. 87 indexed citations

13.

Blom, Dirk, A. David Marais, Kjetil Retterstøl, et al.. (2008). Rosuvastatin reduces non–high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia). Journal of clinical lipidology. 2(6). 418–425. 7 indexed citations

14.

Deedwania, Prakash, Milan Gupta, Michael Stein, J. Ycas, & Alex Gold. (2007). Comparison of Rosuvastatin Versus Atorvastatin in South-Asian Patients at Risk of Coronary Heart Disease (from the IRIS Trial). The American Journal of Cardiology. 99(11). 1538–1543. 53 indexed citations

15.

Insull, William, Jalal K. Ghali, David Hassman, et al.. (2007). Achieving Low-Density Lipoprotein Cholesterol Goals in High-Risk Patients in Managed Care: Comparison of Rosuvastatin, Atorvastatin, and Simvastatin in the SOLAR Trial. Mayo Clinic Proceedings. 82(5). 543–550. 32 indexed citations

16.

Stein, Michael, et al.. (2006). Tu-W20:6 First large randomized trial of statin therapy in South Asian patients at risk for coronary heart disease: The iris trial. Atherosclerosis Supplements. 7(3). 161–161. 2 indexed citations

17.

Ycas, J., et al.. (2006). Comparison of Rosuvastatin Versus Atorvastatin in Hispanic-Americans With Hypercholesterolemia (from the STARSHIP Trial). The American Journal of Cardiology. 98(6). 768–773. 29 indexed citations

18.

Ferdinand, Keith C., Luther T. Clark, Karol E. Watson, et al.. (2005). Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin in African-American Patients in a Six-Week Trial. The American Journal of Cardiology. 97(2). 229–235. 56 indexed citations

19.

Ycas, J. & Richard W. Zobel. (1983). The response of maize radicle orientation to soil solution and soil atmosphere. Plant and Soil. 70(1). 27–35. 7 indexed citations

20.

Greenwood, Michael S. & J. Ycas. (1975). The role of stelar auxin in the development of the primary root of Zea mays. Planta. 122(3). 311–314. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact